MEA Synthetic Biology Market Size to Hit USD 1.35 Billion by 2026

MEA Synthetic Biology Market (By Product: Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism; By Technology: NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies; By Application: Healthcare, Clinical, Non-healthcare; By End Use: Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Others) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 585 | Published : 08 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 1.14 Bn

Forecast Year,

USD 6.07 Bn

CAGR, 2026 - 2035

18.2%

Report Coverage

MEA

Download Databook

The Middle East and Africa synthetic biology market size was evaluated at USD 1.14 billion in 2025 and is expected to grow around USD 6.07 billion by 2035, registering a CAGR of 18.2%from 2026 to 2035. Rising biotech investments, government initiatives, and technological advancements are some of the major factors that help fuel the growth of the market.

MEA Synthetic Biology Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 1.14 Billion
Market Size in 2026	USD 1.35 Billion
Market Size by 2035	USD 6.07 Billion
CAGR 2026 to 2035	18.2%
Base Year	2025
Forecast Period	2026 to 2035

The Middle East and Africa synthetic biology market is also expected to grow due to the diversification of oil-dependent economies through biotechnology and personalized medicine . The rising prevalence of chronic and genetic diseases, leading to a higher need for synthetic biology-based diagnostics and targeted therapies, is also one of the major market drivers.

MEA Synthetic Biology Market, By Product Outlook 2025 (%)

Segments	Shares (%)
Oligonucleotide / Oligo Pools & Synthetic DNA	32%
Enzymes	18%
Cloning Technology Kits	14%
Xeno-Nucleic Acids	8%
Chassis Organism	28%

Oligonucleotide / Oligo Pools & Synthetic DNA - The segment holds 32% of the market share and is driven by growing demand for gene synthesis, molecular research, and expanding adoption of synthetic biology tools.
Enzymes - The segment captures 18.50% of the market share and is driven by its essential role in DNA manipulation, amplification, and bioprocessing reactions.
Cloning Technologies Kits - The segment has a notable share of 14%, as the segment's growth is supported by ongoing research activities and growing use in genetic engineering workflows.

MEA Synthetic Biology Market, By Technology Outlook 2025 (%)

Segments	Shares (%)
NGS Technology	21%
PCR Technology	19%
Genome Editing Technology	27%
Bioprocessing Technologies	23%
Other Technologies	10%

NGS Technology - The segment has a significant share of 24% of the market and is driven by rising demand for high-throughput sequencing and genomic analysis.
PCR Technology - The segment holds 21.50% of the market share due to its essential role in molecular diagnostics and research applications.
Genome Editing Technology - The segment has a notable share of 26% of the market and is driven by higher adoption of technologies like CRISPR and other advanced gene editing platforms..

MEA Synthetic Biology Market, By Application Outlook 2025 (%)

Segments	Shares (%)
Healthcare	60%
Non-Healthcare	40%

Healthcare - The segment holds 41% of the market share and is driven by higher usage in drug development, gene therapy , and precision medicine initiatives.
Non-Healthcare - The segment has a significant share of 59% of the market and is driven by strong adoption in industrial biotechnology, agriculture, and environmental applications.

MEA Synthetic Biology Market, By End Use Outlook 2025 (%)

Segments	Shares (%)
Biotechnology and Pharmaceutical Companies	52%
Academic and Research Institutes	33%
Others (including Dental Clinics, etc.)	15%

Biotechnology and Pharmaceutical Companies - The segment has a significant share of 48% of the market and is driven by strong R&D investments, along with increasing integration of synthetic biology in drug discovery.
Academic and Research - The segment has a notable share of 32% and is supported by strong research funding and innovation-focused initiatives.

Top Companies in the MEA Synthetic Biology Market

Bota Biosciences Inc.
Codexis, Inc.
Creative Biogene.
Creative Enzymes.
Enbiotix, Inc.
Illumina, Inc.
Merck Kgaa (Sigma-Aldrich Co. Llc)
New England Biolabs
Eurofins Scientific
Novozymes
Pareto Bio, Inc.
Scarab Genomics, Llc
Synthego
Synthetic Genomics Inc.
Thermo Fisher Scientific, Inc.

Segments Covered in the Report

By Product

Oligonucleotide/Oligo Pools and Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism

By Technology

NGS Technology
PCR Technology
Genome Editing Technology
Bioprocessing Technology
Other Technologies

By Application

Healthcare
- Clinical
  - Bio/Pharmaceuticals
  - Diagnostics
- Non-Clinical
Non-healthcare
- Biotech Crops
- Specialty Chemicals
- Bio-fuels
- Others

By End Use

Biotechnology and Pharmaceutical companies
Academic and Research Institutes
Others

List of Tables & Figures

List of Tables

Table 1: MEA Synthetic Biology Market Size, by Product, 2025-2035 (USD Billion)
Table 2: MEA Synthetic Biology Market Size, by Technology, 2025-2035 (USD Billion)
Table 3: MEA Synthetic Biology Market Size, by Application, 2025-2035 (USD Billion)
Table 4: MEA Synthetic Biology Market Size, by End Use, 2025-2035 (USD Billion)
Table 5: MEA Synthetic Biology Market Size, by Region, 2025-2035 (USD Billion)
Table 6: MEA Synthetic Biology Market Size, by Oligonucleotide/Oligo Pools and Synthetic DNA, 2025-2035 (USD Billion)
Table 7: MEA Synthetic Biology Market Size, by Enzymes, 2025-2035 (USD Billion)
Table 8: MEA Synthetic Biology Market Size, by Cloning Technologies Kits, 2025-2035 (USD Billion)
Table 9: MEA Synthetic Biology Market Size, by Xeno-Nucleic Acids, 2025-2035 (USD Billion)
Table 10: MEA Synthetic Biology Market Size, by Chassis Organism, 2025-2035 (USD Billion)
Table 11: MEA Synthetic Biology Market Size, by NGS Technology, 2025-2035 (USD Billion)
Table 12: MEA Synthetic Biology Market Size, by PCR Technology, 2025-2035 (USD Billion)
Table 13: MEA Synthetic Biology Market Size, by Genome Editing Technology, 2025-2035 (USD Billion)
Table 14: MEA Synthetic Biology Market Size, by Bioprocessing Technology, 2025-2035 (USD Billion)
Table 15: MEA Synthetic Biology Market Size, by Other Technologies, 2025-2035 (USD Billion)
Table 16: MEA Synthetic Biology Market Size, by Healthcare Application, 2025-2035 (USD Billion)
Table 17: MEA Synthetic Biology Market Size, by Clinical Application, 2025-2035 (USD Billion)
Table 18: MEA Synthetic Biology Market Size, by Non-Healthcare Application, 2025-2035 (USD Billion)
Table 19: MEA Synthetic Biology Market Size, by Biotechnology and Pharmaceutical Companies, 2025-2035 (USD Billion)
Table 20: MEA Synthetic Biology Market Size, by Academic and Research Institutes, 2025-2035 (USD Billion)
Table 21: MEA Synthetic Biology Market Size, by Others End Use, 2025-2035 (USD Billion)
Table 22: Turkey Synthetic Biology Market Size, 2025-2035 (USD Billion)
Table 23: GCC Countries Synthetic Biology Market Size, 2025-2035 (USD Billion)
Table 24: Africa Synthetic Biology Market Size, 2025-2035 (USD Billion)

List of Figures

Figure 1: MEA Synthetic Biology Market Share, by Product, 2025 (%)
Figure 2: MEA Synthetic Biology Market Share, by Technology, 2025 (%)
Figure 3: MEA Synthetic Biology Market Share, by Application, 2025 (%)
Figure 4: MEA Synthetic Biology Market Share, by End Use, 2025 (%)
Figure 5: MEA Synthetic Biology Market Share, by Region, 2025 (%)
Figure 6: MEA Synthetic Biology Market Forecast, 2025-2035 (USD Billion)
Figure 7: Oligonucleotide and Synthetic DNA Segment Forecast, 2025-2035 (USD Billion)
Figure 8: Enzymes Segment Forecast, 2025-2035 (USD Billion)
Figure 9: Cloning Technologies Kits Segment Forecast, 2025-2035 (USD Billion)
Figure 10: Xeno-Nucleic Acids Segment Forecast, 2025-2035 (USD Billion)
Figure 11: Chassis Organism Segment Forecast, 2025-2035 (USD Billion)
Figure 12: NGS Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 13: PCR Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 14: Genome Editing Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 15: Bioprocessing Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 16: Healthcare Application Market Forecast, 2025-2035 (USD Billion)
Figure 17: Clinical Application Market Forecast, 2025-2035 (USD Billion)
Figure 18: Non-Healthcare Application Market Forecast, 2025-2035 (USD Billion)
Figure 19: Biotechnology and Pharmaceutical Companies Segment Forecast, 2025-2035 (USD Billion)
Figure 20: Academic and Research Institutes Segment Forecast, 2025-2035 (USD Billion)
Figure 21: MEA Country-wise Market Comparison, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026